Caforio A.L., Pankuweit S., Arbustini E. et al. (2013) Cur-
rent state of knowledge on aetiology, diagnosis, management and ther-
apy of myocarditis: a position statement of the ESC Working group on
myocardial and pericardial diseases. Eur. Heart J., Vol. 34(33): 2636–
48. doi: 10.1093/eurheartj/eht210.
19.
Cecco C.N.D., Monti C.B. (2020) Use of Early T1 Mapping for
MRI in Acute Myocarditis. Radiology, Vol. 295(2): 326–327. doi: 10.1148/
radiol.2020200171.
20.
Chen W., Jeudy J. (2019) Assessment of Myocarditis: Cardiac
MR, PET/CT, or PET/MR? Curr. Cardiol Rep., Vol. 21(8): 76. doi:10.1007/
s11886–019–1158–0.
21.
Cherniuk S. (2019) Speckle-tracking parameters as predictors
of left ventricular systolic dysfunction in patients with myocarditis. Za-
porozhye medical journal Запорізький медичний журнал, Vol. 5 (21):
576—581. DOI: 10.14739/2310–1210.2019.5.179404.
22.
Chimenti C., Verardo R., Scopelliti F. et al. (2017) Myo-
cardial expression of Toll-like receptor 4 predicts the response to im-
munosuppressive therapy in patients with virus-negative chronic inflam-
matory cardiomyopathy. Eur. J. Heart Fail., Vol. 19(7): 915–925. doi:
10.1002/ejhf.796.
23.
Corsten M., Heggermont W., Papageorgiou A.P. et al. (2015) The microRNA-221/-222 cluster balances the antiviral and inflam-
matory response in viral myocarditis. Eur. Heart J., Vol. 36: 909–19. doi:
10.1093/eurheartj/ehv321.
24.
Ebert M., Richter S., Dinov B. et al. (2019) Evaluation
and management of ventricular tachycardia in patients with dilated
cardiomyopathy. Heart Rhythm., Vol. 16(4): 624–631. doi: 10.1016/j.
hrthm.2018.10.028.
25.
Eichhorn C., Bière L., Schnell F. et al. (2019) Myocardi-
tis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncer-
tainties. JACC Cardiovasc Imaging, Vol. 13: 494–507. doi: 10.1016/j.
jcmg.2019.01.039.
26.
